Evidence map›Paper›PMID 42674966›Full record

ArticleAJNR. American journal of neuroradiology2026

Reporting Clinically Actionable Imaging Features of Intracerebral Hemorrhage: A Survey of Neuroradiologist Practice.

Niloufar Valizadeh, Hediyeh Baradaran, Ajay Malhotra, Javier M Romero, Shahram Majidi, David Roh, Santosh B Murthy, Guido J Falcone, Kevin N Sheth, Seyedmehdi Payabvash

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in AJNR. American journal of neuroradiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Niloufar ValizadehFrom the Department of Neurosurgery (N.V., S.M.), Mount Sinai Hospital, New York, NY; Department of Radiology (H.B., S.P.), Neurology (D.R.), Columbia University Irving Medical Center, New York, NY; Department of Radiology and Biomedical Imaging (A.M.), Neurology (G.J.F., K.N.S.), Yale School of Medicine, New Haven, CT 06520.; Department of Radiology (J.M.R.), Massachusetts General Hospital, Boston, MA and Department of Neurology (S.B.M.), Weill Cornell Medical College, Cornell University, New York, NY.
Hediyeh BaradaranFrom the Department of Neurosurgery (N.V., S.M.), Mount Sinai Hospital, New York, NY; Department of Radiology (H.B., S.P.), Neurology (D.R.), Columbia University Irving Medical Center, New York, NY; Department of Radiology and Biomedical Imaging (A.M.), Neurology (G.J.F., K.N.S.), Yale School of Medicine, New Haven, CT 06520.; Department of Radiology (J.M.R.), Massachusetts General Hospital, Boston, MA and Department of Neurology (S.B.M.), Weill Cornell Medical College, Cornell University, New York, NY.
Ajay MalhotraFrom the Department of Neurosurgery (N.V., S.M.), Mount Sinai Hospital, New York, NY; Department of Radiology (H.B., S.P.), Neurology (D.R.), Columbia University Irving Medical Center, New York, NY; Department of Radiology and Biomedical Imaging (A.M.), Neurology (G.J.F., K.N.S.), Yale School of Medicine, New Haven, CT 06520.; Department of Radiology (J.M.R.), Massachusetts General Hospital, Boston, MA and Department of Neurology (S.B.M.), Weill Cornell Medical College, Cornell University, New York, NY.
Javier M RomeroFrom the Department of Neurosurgery (N.V., S.M.), Mount Sinai Hospital, New York, NY; Department of Radiology (H.B., S.P.), Neurology (D.R.), Columbia University Irving Medical Center, New York, NY; Department of Radiology and Biomedical Imaging (A.M.), Neurology (G.J.F., K.N.S.), Yale School of Medicine, New Haven, CT 06520.; Department of Radiology (J.M.R.), Massachusetts General Hospital, Boston, MA and Department of Neurology (S.B.M.), Weill Cornell Medical College, Cornell University, New York, NY.
Shahram MajidiFrom the Department of Neurosurgery (N.V., S.M.), Mount Sinai Hospital, New York, NY; Department of Radiology (H.B., S.P.), Neurology (D.R.), Columbia University Irving Medical Center, New York, NY; Department of Radiology and Biomedical Imaging (A.M.), Neurology (G.J.F., K.N.S.), Yale School of Medicine, New Haven, CT 06520.; Department of Radiology (J.M.R.), Massachusetts General Hospital, Boston, MA and Department of Neurology (S.B.M.), Weill Cornell Medical College, Cornell University, New York, NY.
David RohFrom the Department of Neurosurgery (N.V., S.M.), Mount Sinai Hospital, New York, NY; Department of Radiology (H.B., S.P.), Neurology (D.R.), Columbia University Irving Medical Center, New York, NY; Department of Radiology and Biomedical Imaging (A.M.), Neurology (G.J.F., K.N.S.), Yale School of Medicine, New Haven, CT 06520.; Department of Radiology (J.M.R.), Massachusetts General Hospital, Boston, MA and Department of Neurology (S.B.M.), Weill Cornell Medical College, Cornell University, New York, NY.
Santosh B MurthyFrom the Department of Neurosurgery (N.V., S.M.), Mount Sinai Hospital, New York, NY; Department of Radiology (H.B., S.P.), Neurology (D.R.), Columbia University Irving Medical Center, New York, NY; Department of Radiology and Biomedical Imaging (A.M.), Neurology (G.J.F., K.N.S.), Yale School of Medicine, New Haven, CT 06520.; Department of Radiology (J.M.R.), Massachusetts General Hospital, Boston, MA and Department of Neurology (S.B.M.), Weill Cornell Medical College, Cornell University, New York, NY.
Guido J FalconeFrom the Department of Neurosurgery (N.V., S.M.), Mount Sinai Hospital, New York, NY; Department of Radiology (H.B., S.P.), Neurology (D.R.), Columbia University Irving Medical Center, New York, NY; Department of Radiology and Biomedical Imaging (A.M.), Neurology (G.J.F., K.N.S.), Yale School of Medicine, New Haven, CT 06520.; Department of Radiology (J.M.R.), Massachusetts General Hospital, Boston, MA and Department of Neurology (S.B.M.), Weill Cornell Medical College, Cornell University, New York, NY.
Kevin N ShethFrom the Department of Neurosurgery (N.V., S.M.), Mount Sinai Hospital, New York, NY; Department of Radiology (H.B., S.P.), Neurology (D.R.), Columbia University Irving Medical Center, New York, NY; Department of Radiology and Biomedical Imaging (A.M.), Neurology (G.J.F., K.N.S.), Yale School of Medicine, New Haven, CT 06520.; Department of Radiology (J.M.R.), Massachusetts General Hospital, Boston, MA and Department of Neurology (S.B.M.), Weill Cornell Medical College, Cornell University, New York, NY.
Seyedmehdi PayabvashFrom the Department of Neurosurgery (N.V., S.M.), Mount Sinai Hospital, New York, NY; Department of Radiology (H.B., S.P.), Neurology (D.R.), Columbia University Irving Medical Center, New York, NY; Department of Radiology and Biomedical Imaging (A.M.), Neurology (G.J.F., K.N.S.), Yale School of Medicine, New Haven, CT 06520.; Department of Radiology (J.M.R.), Massachusetts General Hospital, Boston, MA and Department of Neurology (S.B.M.), Weill Cornell Medical College, Cornell University, New York, NY. sp4479@cumc.columbia.edu.

Funding

Anticoagulation in Intracerebral Hemorrhage Survivors with Atrial Fibrillation and Imaging Features of Cerebral Amyloid Angiopathy and Small Vessel DiseaseR01NS140459 · NINDS · YALE UNIVERSITY · PI Guido Jose Falcone, Santosh Bhaskar Murthy · 2025 to 2026
$1.2M
Radiomics Signatures and Patient Outcomes in Intracerebral HemorrhageK23NS118056 · NINDS · YALE UNIVERSITY · PI Seyedmehdi Payabvash · 2021 to 2026
$780k
NINDS NIH HHS K23 NS118056NINDS NIH HHS R01 NS140459
6 · The paper itself

Abstract

background and purposeRecent advances in spontaneous intracerebral hemorrhage (ICH) management increasingly expand the role of neuroimaging beyond diagnosis to potentially guide time-sensitive therapies and targeted clinical trial enrollment. We surveyed neuroradiologists to characterize current ICH imaging and reporting practices and identify opportunities for quality improvement. MATERIALS AND

methodsAn anonymous 52-item electronic survey was distributed through the American Journal of Neuroradiology Survey Corner and REDCap between April and May 2026. Survey domains included imaging acquisition, reporting practices, hematoma volume quantification, assessment of hematoma expansion predictors, ICH localization, etiologic assessment, and follow-up imaging. Responses were summarized using descriptive statistics.

resultsA total of 267 neuroradiologists completed the survey. Nearly all respondents (97.3%) reported 24/7 emergency head CT interpretation coverage. However, 41.5% did not routinely quantify hematoma volume, only 45% reported routine CTA acquisition for patients with ICH, and 30% rarely or only occasionally recommended CTA when it was not performed. While 91.3% routinely reported a positive CTA spot-sign, only 43.0% almost always assessed non-contrast CT predictors of hematoma expansion. Confidence in hemorrhage localization when crossing anatomical boundaries and etiologic classification was modest, and 45.8% routinely used the Boston Criteria version 2.0 for MRI-based assessment of cerebral amyloid angiopathy.

conclusionsContemporary neuroradiology practice demonstrates several readily addressable gaps in ICH imaging and reporting, including hematoma volume quantification, routine vascular imaging, standardized assessment of hematoma expansion imaging markers, and etiologic assessment. Standardizing these practices can improved image guided risk-stratification and facilitate implementation of emerging time-sensitive ICH therapies.

Identifiers

PMID42674966
PMCPMC13616481

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.